argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
23 jun 2024 - 18:04
Statutory name
argenx SE
Title
argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy
Date last update: 03 April 2026